LCK
VRDN icon

LeRoy C. Kopp’s Viridian Therapeutics VRDN Stock Holding History

LeRoy C. Kopp’s Portfolio VRDN Stock Details VRDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$3.6M Buy
+205,640
New +$3.99M 2.06% 12

Other funds holding VRDN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

LeRoy C. Kopp's VRDN Position: Q1 2024 in Review

LeRoy C. Kopp opened a new position in Viridian Therapeutics (VRDN) in Q1 2024: 205,640 shares worth $3.6M. The stake represents 2.06% of the portfolio and ranks #12 among its holdings.

136 funds tracked by Wall St. Rank hold VRDN as of Q1 2024.

  • LeRoy C. Kopp held 205,640 shares of Viridian Therapeutics worth $3.6M as of Q1 2024.
  • Viridian Therapeutics was a new LeRoy C. Kopp position in Q1 2024.
  • Viridian Therapeutics made up 2.06% of LeRoy C. Kopp's portfolio in Q1 2024, its #12 holding.
  • 136 funds tracked by Wall St. Rank held Viridian Therapeutics as of Q1 2024.

Based on LeRoy C. Kopp's 13F filing for Q1 2024, filed 3 Jun 2024.